150 million doses developed by Oxford, as the agreement reached with Argentina covers initial production.
The Oxford University coronavirus vaccine developed will be produced in Mexico if its advanced trials are successful and it receives regulatory approval as cases in the country hit half a million.
President Andres Manuel Lopez Obrador said the agreement with pharmaceutical company AstraZeneca, which also provides for production in Argentina, should result in a vaccine that the government would provide free starting in the first quarter of 2021.
However, access the vaccine would be universal and free in Mexico which has registered nearly 55,000 Covid-19 deaths, as the third highest toll in the world behind United State and Brazil.
“In other countries, they can decide to charge or select who is vaccinated and who not, but so there isn’t any doubt and to guarantee to all our people, all Mexicans are going to have access to the vaccine,” Lopez Obrador said at a news conference.
Brazil as already reached its own agreement with the drugmaker, while Mexico and Argentina would allow for production throughout Latin America.
The agreement covers an initial production of 150 million doses for the region, with the possibility of increasing to 400 million doses.
The Mexican Mogul Carlos Slim who once the world’s richest man will found the production of the vaccine.
Mexico already has agreements with four vaccine projects to carry out Phase III trials in the country, but this is the first production agreement.
that researchers around the world are racing to prove safe and efficient.
The government of Mexico has been criticised for their management of the coronavirus pandemic and reluctance to put money into the economy recovery.
Mexico reported 7,371 new confirmed cases bringing all the total in the country to 505,751. The government has said the real number of infected people is likely significantly higher than the confirmed cases.